Obesity Science & Practice (Jun 2020)

Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease

  • Steven K. Malin,
  • Sankar D. Navaneethan,
  • Ciaran E. Fealy,
  • Amanda Scelsi,
  • Hazel Huang,
  • Michael Rocco,
  • John P. Kirwan

DOI
https://doi.org/10.1002/osp4.408
Journal volume & issue
Vol. 6, no. 3
pp. 307 – 312

Abstract

Read online

Summary Introduction The incidence of chronic kidney disease (CKD) has increased in recent years. CKD is associated with obesity, type 2 diabetes, and cardiovascular disease, although the mechanism remains unclear. Elevated soluble form of the receptor for advanced glycation end products ( RAGE) is related to proinflammatory signaling pathways that may promote diabetic nephropathy and vascular dysfunction. Because lifestyle modification reduces systematic inflammation in adults with obesity and hyperglycaemia, the hypothesis that exercise plus caloric restriction would lower soluble RAGE in adults with CKD was tested in this study. Methods Eight adults (n = 6 females; age: 56.3 ± 2.8 y; BMI: 43.7 ± 2.2 kg/m2; 2‐h OGTT glucose: 215 ± 9.8 mg/dL; eGFR: 49.6 ± 3.3 mL/min/1.73 m2) were enrolled in a 12‐week pilot lifestyle intervention (supervised aerobic exercise [5 d/wk, up to 60 min/d at approximately 65%‐85% HRmax] plus low‐fat dietary counseling). Body composition (DXA), aerobic fitness (VO2max), insulin sensitivity (120 min 75 g OGTT; Matsuda Index), plasma levels of soluble RAGE and fetuin‐A were measured before and after the intervention. Results Exercise reduced body weight, fasting glucose, and fetuin‐A as well as increased VO2max, glucose tolerance, and insulin sensitivity (all P < .05). Lifestyle intervention decreased plasma soluble RAGE (pre: 1018.1 ± 163 vs post: 810.6 ± 119.6 ng/mL; P = .02), and the decrease was associated with a lower 2‐hour blood glucose (r = 0.76, P = .03) and with increased insulin sensitivity (r = −0.90, P < .01). Conclusions Exercise and caloric restriction are effective at lowering soluble RAGE in relation to glucose regulation in patients with CKD.

Keywords